Journal of Peking University(Health Sciences) ›› 2018, Vol. 50 ›› Issue (6): 949-951. doi: 10.19723/j.issn.1671-167X.2018.06.001
• Article • Next Articles
CLC Number:
| [1] |
Bohan A, Peter JB . Polymyositis and dermatomyositis (first of two parts)[J]. N Engl J Med, 1975,292(7):344-347.
doi: 10.1056/NEJM197502132920706 |
| [2] |
Bohan A, Peter JB . Polymyositis and dermatomyositis (second of two parts)[J]. N Engl J Med, 1975,292(8):403-407.
doi: 10.1056/NEJM197502202920807 |
| [3] |
Venalis P, Lundberg IE . Immune mechanisms in polymyositis and derrnatomyositis and potential targets for therapy[J]. Rheumatology (Oxford), 2014,53(3):397-405.
doi: 10.1093/rheumatology/ket279 pmid: 23970542 |
| [4] |
Dalakas MC . Inflammatory muscle diseases[J]. N Engl J Med, 2015,372(18):1734-1747.
doi: 10.1056/NEJMra1402225 |
| [5] |
Lu X, Peng Q, Wang G . Discovery of new biomarkers of idiopathic inflammatory myopathy[J]. Clin Chim Acta, 2015,444:117-125.
doi: 10.1016/j.cca.2015.02.007 pmid: 25681646 |
| [6] |
Dalakas M . Polymyositis, dermatomyositis, and inclusion-body myositis[J]. N Engl J Med, 1991,325(21):1487-1498.
doi: 10.1056/NEJM199111213252107 pmid: 1658649 |
| [7] |
Tanimoto K, Nakano K, Kano S , et al. Classification criteria for polymyositis and dermatomyositis[J]. J Rheumatol, 1995,22(4):668-674.
doi: 10.1002/art.1780380424 pmid: 7791161 |
| [8] |
Targoff I, Miller F, Medsger T , et al. Classification criteria for the idiopathic inflammatory myopathies[J]. Curr Opin Rheumatol, 1997,9(6):527-535.
doi: 10.1097/00002281-199711000-00008 pmid: 9375282 |
| [9] |
Dalakas MC, Hohlfeld R . Polymyositis and dermatomyositis[J]. Lancet, 2003,362(9388):971-982.
doi: 10.1016/S0140-6736(03)14368-1 |
| [10] |
Hoogendijk JE, Amato AA, Lecky BR , et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands[J]. Neuromuscul Disord, 2004,14(5):337-345.
doi: 10.1016/j.nmd.2004.02.006 pmid: 15099594 |
| [11] |
DeBleecker JL, Lundberg IE, De Visser M . 193rd ENMC Myositis Muscle Biopsy Study Group. 193rd ENMC International Workshop Pathology Diagnosis of Idiopathic Inflammatory Myopathies 30 November-2 December 2012, Naarden, the Netherlands[J]. Neuromuscul Disord, 2013,23(11):945-951.
doi: 10.1016/j.nmd.2013.07.007 pmid: 24011698 |
| [12] |
DeBleecker JL, De Paepe B, Aronica E , et al. 205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies Part Ⅱ 28-30 March 2014, Naarden, The Netherlands[J]. Neuromuscul Disord, 2015,25(3):268-272.
doi: 10.1016/j.nmd.2014.12.001 pmid: 25572016 |
| [13] |
De Bleecker JL, Vervaet V , Van den Bergh P. Necrotizing myopathy with microvascular deposition of the complement membrane attack complex[J]. Clin Neuropathol, 2004,23(2):76-79.
doi: 10.1016/j.clineuro.2003.12.001 pmid: 15074581 |
| [14] |
Takada T, Hirakata M, Suwa A , et al. Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies[J]. Mod Rheumatol, 2009,19(2):156-164.
doi: 10.3109/s10165-008-0139-8 |
| [15] |
Christopher-Stine L, Casciola-Rosen LA, Hong G , et al. A novel autoantibody recognizing 200-kD and 100-kD proteins is associated with an immune-mediated necrotizing myopathy[J]. Arthritis Rheum, 2010,62(9):2757-2766.
doi: 10.1002/art.27572 pmid: 3026777 |
| [16] |
Ge Y, Lu X, Peng Q , et al. Clinical characteristics of anti-3-hydroxy-3-methylglutaryl coenzyme a reductase antibodies in Chinese patients with idiopathic inflammatory myopathies[J]. PLoS One, 2015,10(10):e0141616.
doi: 10.1371/journal.pone.0141616 pmid: 4624805 |
| [17] |
Allenbach Y , DrouotL, RigoletA, et al. Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin[J]. Medicine (Baltimore), 2014,93(3):150-157.
doi: 10.1097/MD.0000000000000028 |
| [18] |
Wang L, Liu L, Hao H , et al. Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients[J]. Neuromuscul Disord, 2014,24(4):335-341.
doi: 10.1016/j.nmd.2014.01.002 pmid: 24491486 |
| [19] |
Allenbach Y, Mammen AL, Benveniste O , et al. 224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies, The Netherlands, 14-16 October 2016[J]. Neuromuscul Disord, 2018,28(1):87-99.
doi: 10.1016/j.nmd.2017.09.016 |
| [20] |
Van der Meulen MF, Bronner M, Hoogendijk JE , et al. Polymyositis: a diagnostic entity reconsidered[J]. Neurology, 2003,61(3):316-321.
doi: 10.1212/WNL.61.3.316 |
| [21] |
Kishi T, Rider LG, Pak K , et al. Association of anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibodies with DRB1 *07:01 and severe myositis in juvenile myositis patients [J]. Arthritis Care Res (Hoboken), 2017,69(7):1088-1094.
doi: 10.1002/acr.v69.7 |
| [22] |
Lundberg IE, Tjärnlund A, Bottai M , et al. European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups[J]. Arthritis Rheumatol, 2017,69(12):2271-2282.
doi: 10.1002/art.40320 |
| [1] | Hui WEI, Jingfeng ZHANG, Zhongqiang YAO, Jinxia ZHAO. Clinical characteristics and relevant factors of rheumatoid arthritis patients with anemia of chronic disease [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 307-312. |
| [2] | Jiyan CHU, Ping LI, Jing TIAN, Diyu FU, Lin GUO, Rui SUN, Yadi LI. Expression of the melanoma 2-mediated pyroptosis pathway in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 175-183. |
| [3] | Yuan LIU, Guixiu SHI. Change from Sjögren syndrome to Sjögren disease [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1015-1017. |
| [4] | Yirui LIAN, Jingxuan LIU, Liang ZHAO, Jing ZHAO, Sitian ZANG, Yuhui LI. Rheumatic disease spectrum and immunological profile of anti-PM/Scl antibodies in idiopathic inflammatory myopathies [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1018-1023. |
| [5] | Tao WU, Jianzi LIN, Yafeng ZHU, Jianda MA, Peiwen JIA, Lijuan YANG, jie PAN, Yaowei ZOU, Ying YANG, Ye LU, Lie DAI. Serum inter-alpha-trypsin inhibitor heavy chain H3 is identified as a potential biomarker for myopenia in patients with rheumatoid arthritis using proteomic profiling [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1024-1031. |
| [6] | Wenhao LIN, Yang XIE, Fangqing WANG, Shuying WANG, Xiangjun LIU, Fanlei HU, Yuan JIA. Single-cell RNA sequencing of B cells reveals molecular typing in Sjögren syndrome [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1032-1041. |
| [7] | Zhao XIANG, Li YANG, Jing YANG. Untargeted metabolomics reveals differential serum metabolites and metabolic pathways in patients with primary Sjögren syndrome and thrombocytopenia [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1042-1050. |
| [8] | Yayun ZHAO, Mengfan NI, Xue LI, Bei WANG, Gong CHENG, Jing HE, Yuebo JIN. Clinical efficacy and safety of rituximab in treating renal injury in primary Sjögren syndrome [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1051-1060. |
| [9] | Jiajing PENG, Li CUI. Clinical features and prognosis of sarcoidosis with ocular lesions as the initial manifestation [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1061-1066. |
| [10] | Yajing GAO, Zhengfang LI, Mengsi MA, Lijun WU. Role of the SII and SIRI in risk prediction, disease activity assessment, and prog-nostic evaluation of Behçet disease uveitis [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1067-1073. |
| [11] | Xiaolin WANG, Shaoyi GUO, Dazhao CHEN, Xijie WEN, Yong HUA, Liang ZHANG, Qin ZHANG. A follow-up study on total hip arthroplasty in patients with systemic lupus erythematosus combined with osteonecrosis of femoral head [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1081-1088. |
| [12] | Xinfeng WU, Siliang MAN, Dazhao CHEN, Yong HUA, Xijie WEN, Yingyue DING, Liang ZHANG, Xiujuan HOU. A long-term review for radiographic parameters of hips in axial spondyloarthritis patients with end-stage hip involvement: A 24-year trend analysis from a single high-volume tertiary center [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1089-1095. |
| [13] | Jingwen LAN, Zhe CHEN, Yongjing CHENG, Like ZHAO. Clinical characteristics, efficacy and safety of antifibrotic agents in elderly patients with connective tissue disease-associated interstitial lung disease [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1101-1106. |
| [14] | Yanyan LI, Xiangjun LIU, Gongming LI, Chun LI, Yuan JIA. Clinic behavior and therapeutic status of patients with antiphospholipid syndrome [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1107-1112. |
| [15] | Chun WEI, Yue YANG, Xinju ZHAO, Xu LIU, Yuan JIA. Systemic lupus erythematosus complicated by autoimmune nodopathy: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1174-1179. |
|
||